Last --
Change Today 0.00 / 0.00%
Volume 0.0
WKCMY On Other Exchanges
Symbol
Exchange
Xetra
OTC US
OTC US
All times are local (Market data is delayed by at least 15 minutes).

wacker chemie ag-unspon adr (WKCMY) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
05/13/14
P/E TM
--
Dividend
$0.07
Dividend Yield
--
Current Stock Chart for WACKER CHEMIE AG-UNSPON ADR (WKCMY)

Related News

No related news articles were found.

wacker chemie ag-unspon adr (WKCMY) Related Businessweek News

No Related Businessweek News Found

wacker chemie ag-unspon adr (WKCMY) Details

Wacker Chemie AG provides specialty chemical products worldwide. It operates through five divisions: WACKER SILICONES, WACKER POLYMERS, WACKER BIOSOLUTIONS, WACKER POLYSILICON, and Siltronic. The WACKER SILICONES division offers a portfolio of approximately 2,800 products ranging from silicone fluids and emulsions, resins, elastomers, and sealants, to silanes and pyrogenic silica grades, which are used as starting materials in the production of silicones. The WACKER POLYMERS division manufactures binders and polymeric additives, such as dispersible polymer powders and dispersions used in various industrial applications, or as base chemicals in paints, coatings, paper, and adhesives industries, as well as in the construction industry. The WACKER BIOSOLUTIONS division supplies customized biotech and catalog products for fine chemical sector, including pharmaceutical proteins, cyclodextrins, cysteine, polyvinyl acetate solid resins, organic intermediates, and acetylacetone. This division focuses on customer-specific solutions in the areas of food additives, pharmaceutical actives, and agrochemicals. The WACKER POLYSILICON division produces hyperpure polysilicon for the semiconductor, electronics, and solar sectors. The Siltronic division supplies silicon wafers for various semiconductor manufacturers that are used as raw materials for various semiconductor products, including discrete semiconductor components or microchips. The company was founded in 1914 and is headquartered in Munich, Germany.

16,724 Employees
Last Reported Date: 10/30/14
Founded in 1914

wacker chemie ag-unspon adr (WKCMY) Top Compensated Officers

Chief Executive Officer, President and Member...
Total Annual Compensation: €1.4M
Chief Financial Officer and Member of Executi...
Total Annual Compensation: €1.1M
Member of Executive Board
Total Annual Compensation: €1.1M
Member of the Executive Board
Total Annual Compensation: €682.3K
Compensation as of Fiscal Year 2013.

wacker chemie ag-unspon adr (WKCMY) Key Developments

Wacker Chemie AG Presents at 4th Annual Berenberg 1 - 1 Symposium @ German Equity Forum, Nov-26-2014

Wacker Chemie AG Presents at 4th Annual Berenberg 1 - 1 Symposium @ German Equity Forum, Nov-26-2014 . Venue: Maritim Hotel, Theodor-Heuss-Allee 3, 60486 Frankfurt am Main, Germany.

Wacker Chemie AG Presents at UBS European Conference 2014, Nov-12-2014

Wacker Chemie AG Presents at UBS European Conference 2014, Nov-12-2014 . Venue: London, United Kingdom. Speakers: Rudolf Staudigl, Chief Executive Officer, President and Member of Executive Board.

Wacker Chemie Reports Group Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014; Provides Earnings Guidance for the Full Year of 2014

Wacker Chemie reported group earnings results for the third quarter and nine months ended September 30, 2014. The company achieved a year-on-year increase in sales in the period July through September 2014. The Munich-based chemical company generated third-quarter sales of EUR 1,232.2 million compared to EUR 1,165.4 million a year ago, almost 6% more than a year earlier. All five business divisions contributed to this growth, and the Group as a whole almost matched its sales figure for the strong preceding quarter (EUR 1,242.3 million). WACKER's earnings before interest, taxes, depreciation and amortization (EBITDA) in the third quarter 2014 more than doubled relative to the year-earlier period, rising to EUR 347.5 million compared to EUR 167.9 million a year ago. The EBITDA margin rose accordingly to 28.2% from 14.4% in the third quarter of 2013. The Group's third-quarter earnings before interest and taxes (EBIT) were almost six times higher year on year, coming in at EUR 196.3 million compared to EUR 35.1 million a year ago. The corresponding EBIT margin was 15.9% against 3.0% a year ago. Net income for the quarter under review was EUR 119.0 million compared to EUR 5.4 million a year ago and earnings per share amounted to EUR 2.43 compared to EUR 0.09 a year ago. The Group's net cash flow in the third quarter of 2014 was EUR 178.4 million, compared with EUR 164.7 million a year ago, a year-on-year increase of around 8%. Capital expenditures were EUR 152.9 million against EUR 98.2 million a year ago. Group sales were up 6% over last year and at the level of the last quarter. Mainly growing shipments and product mix effects supported this performance. For the nine months, the company reported sales of EUR 3,631.9 million against EUR 3,392.0 million a year ago. EBITDA was EUR 862.2 million against EUR 520.6 million a year ago. EBIT was EUR 412.2 million against EUR 119.8 million a year ago. Income before taxes was EUR 349.8 million against EUR 60.7 million a year ago. Net income for the period was EUR 212.6 million or EUR 4.42 per share against EUR 25.6 million or EUR 0.45 per share a year ago. Net cash flow was EUR 332.5 million against EUR 190.8 million a year ago. Capital expenditures were EUR 343.2 million against EUR 350.7 million a year ago. Net financial debt as at September 30, 2014 was EUR 905.9 million against EUR 688.1 million as at September 30, 2013. The company presented a more specific full-year forecast, now expecting to post earnings before interest, tax, depreciation and amortisation (EBITDA) of around EUR 1 billion, compared with EUR 678.7 million in 2013. The company had previously assumed it would exceed its prior-year EBITDA figure by at least one-third. Full-year EBITDA margin is expected be over 20%. The company is still expecting to post a mid-single-digit percentage increase in Group sales compared to EUR 4.48 billion in 2013. The company's objective is to achieve a markedly positive net cash flow that, from the present standpoint, is expected to be around the prior-year level. Net financial debt will climb by about EUR 300 million. Group net income is expected to be much higher than last year. For the full year, the company now expect the tax rate of about 40%. Full year 2015 -- 2014 CapEx should reach about EUR 550 million, below depreciation of about EUR 600 million.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
WKCMY:US $0.00 USD 0.00

WKCMY Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Arkema SA €54.72 EUR -0.37
Celanese Corp $60.07 USD -0.91
Clariant AG SFr.17.50 CHF -0.19
K+S AG €24.09 EUR -0.215
Lonza Group AG SFr.113.60 CHF +1.60
View Industry Companies
 

Industry Analysis

WKCMY

Industry Average

Valuation WKCMY Industry Range
Price/Earnings 23.7x
Price/Sales 1.0x
Price/Book 2.3x
Price/Cash Flow 24.9x
TEV/Sales 0.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact WACKER CHEMIE AG-UNSPON ADR, please visit www.wacker.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.